Digital Diagnostics is excited to showcase our innovative AI diagnostic solution, LumineticsCore™, for the autonomous detection of diabetic retinopathy at the point-of-care.
AMGA Details
Date: March 26-29, 2025
Location: Gaylord Texan – Grapevine, TX
Booth: #907
Exhibiting Hours:
– March 27th – 5:00PM-7:00PM
– March 28th – 7:00AM-6:30PM
– March 29th – 7:00AM-8:30AM
Schedule a Live Demo
Don’t miss an opportunity to see LumineticsCore in action during a 10 minute demo.
Stop at the booth anytime or schedule some time with us based off your availability.
LumineticsCore™ - Overview | Play Video
Close the care gap: Bring the exam to the patient
LumineticsCore™ is the first ever FDA De Novo cleared fully autonomous AI system for the detection of diabetic retinopathy during the patient encounter.
-
Diagnostic results in real time at the point-of-care
-
Closes HEDIS care gap and reimbursable with CPT Code 92229
-
Simple user interface with no need for specialist overread or telemedicine call backs
-
Algorithm diagnosis within 30 seconds of image submission
Seamlessly integrates into clinical workflows to help reduce administrative burden
-
Operated by existing clinic staff
-
Validated for use in a frontline setting
-
EHR integration allows for automated coding and care gap closure
